Edgewise Therapeutics Inc Share Price

NASDAQ: EWTX

Small Cap

$14.02

+0.32

(+2.34%)

Live

as on September 16, 2025 at 8:41 pm IST

$₹

Edgewise Therapeutics Inc Stock Performance

as on September 16, 2025 at 8:41 pm IST

Day's Low
Day's High
$13.92
Day's Price Range
$14.21
$14.02
0.71%
Downside
1.36%
Upside
52 Week's Low
52 Week's High
$10.6
52-Week Price Range
$38.12
$14.02
24.39%
Downside
171.90%
Upside

Edgewise Therapeutics Inc share price movements today

Previous Close: $13.70
Open: $14.10
Volume: 318.2K
Day's Low - High: $13.92 - $14.21
52 Week Low - High: $10.6 - $38.12

Edgewise Therapeutics Inc Historical Returns

1 Month Return: -3.18 %
3 Month Return: -6.68 %
1 Year Return: -18.74 %
3 Year Return: + 43.01 %
5 Year Return: 0 %

Edgewise Therapeutics Inc Stock Fundamentals & Key Indicators

Check Edgewise Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-1.6177

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-172.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

67431200.00%

Edgewise Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edgewise Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Edgewise Therapeutics Inc	BUY	$1.5B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Edgewise Therapeutics Inc Stock including INR - Dollar returns

The Edgewise Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Edgewise Therapeutics Inc investment value today

Current value as on today

₹88,023

Returns

₹11,977

(-11.98%)

Returns from Edgewise Therapeutics Inc Stock

₹16,845 (-16.84%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Edgewise Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Edgewise Therapeutics Inc. Average target price of $37.5

Edgewise Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Edgewise Therapeutics Inc.

What analysts predicted

62.61%UPSIDE

Target Price

$37.5

Current Price

$14.02

Analyzed by

12 Analysts

Target

$37.50

Edgewise Therapeutics Inc target price $37.5, a slight upside of 62.61% compared to current price of $14.02. According to 12 analysts rating.

Edgewise Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Edgewise Therapeutics Inc Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:167% versus previous 30 day period

Edgewise Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	-	-	2	-	-
Gross Profit	0	0	0	1	0	0	-2	1	0	0
Operating Income	-25	-25	-29	-33	-34	-38	-40	-45	-45	-42
EBITDA	-25	-24	-29	-33	-34	-37	-39	-39	-45	-42
Interest Expense	3	-	-	3	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-22	-21	-25	-30	-28	-31	-34	-39	-40	-36
Income Tax Expense	-3	0	0	3	0	-	-	0	-	-
Net Income	-19	-21	-25	-30	-28	-31	-34	-39	-40	-36
Net Profit Margin	0.00%	0.00%	0.00%	-1338.50%	0.00%	0.00%	0.00%	-1872.62%	0.00%	0.00%

Edgewise Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	-1	-2
Operating Income	-9	-17	-43	-22	-114	-158
EBITDA	-9	-17	-42	-21	-112	-131
Interest Expense	-	0	0	4	-	-
Depreciation	0	0	0	0	1	2
Income Before Tax	-9	-17	-42	-19	-100	-133
Income Tax Expense	0	0	0	-4	-	0
Net Income	-9	-17	-42	-15	-100	-133
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Edgewise Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-21	-25	-30	-28	-31	-34	-39	-40	-36
Operating Cash Flow	-20	-22	-26	-28	-26	-27	-26	-37	-32
Investing Cash Flow	3	23	26	-268	37	25	20	43	-162
Financing Cash Flow	0	0	52	241	1	3	2	2	188
Change in Cash	-16	1	53	-55	13	1	-3	8	-6

Edgewise Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-17	-42	-67	-100	-133
Operating Cash Flow	-14	-33	-52	-91	-109
Investing Cash Flow	-24	-242	-70	102	-184
Financing Cash Flow	120	186	129	53	249
Change in Cash	81	-89	6	64	-44

Global Institutional Holdings in Edgewise Therapeutics Inc

Funds	Holdings
Orbimed Advisors, LLC	14.26%
RA Capital Management, LLC	8.46%
Perceptive Advisors LLC	6.22%
BlackRock Inc	6.16%
Baker Bros Advisors LP	5.84%

See all

Insights on Edgewise Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 73.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 89.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, EWTX stock has moved down by -7.1%

About Edgewise Therapeutics Inc

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.

Organisation	Edgewise Therapeutics Inc
Headquarters	1715 38th Street, Boulder, CO, United States, 80301
Industry	Healthcare
CEO	Dr. Kevin Koch Ph.D.
E-voting on shares	Click here to vote

Key Management of Edgewise Therapeutics Inc

Name	Title
Mr. R. Michael Carruthers	Chief Financial Officer
Mr. John R. Moore J.D.	General Counsel
Dr. Robert Blaustein M.D., Ph.D.	Chief Development Officer
Dr. Kevin Koch Ph.D.	President, CEO & Director
Dr. Behrad Derakhshan Ph.D.	Chief Operating Officer
Dr. Joanne M. Donovan M.D., Ph.D.	Chief Medical Officer
Dr. Alan J. Russell Ph.D.	Co-Founder, Chief Scientific Officer & Director

FAQs

What is Edgewise Therapeutics Inc share price today?

Edgewise Therapeutics Inc share price today is $14.02 as on September 16, 2025 at 8:41 pm IST. Edgewise Therapeutics Inc share today touched a day high of $14.21 and a low of $13.92.

What is the 52 week high and 52 week low for Edgewise Therapeutics Inc share?

Edgewise Therapeutics Inc share touched a 52 week high of $38.12 on November 11, 2024 and a 52 week low of $10.6 on April 7, 2025. Edgewise Therapeutics Inc stock price today i.e. September 16, 2025 at 8:41 pm IST is trending at $14.02,which is 63.22% down from its 52 week high and 32.26% up from its 52 week low.

What is Edgewise Therapeutics Inc's market capitalisation today?

Edgewise Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 8:41 pm IST.

How to invest in Edgewise Therapeutics Inc Stock (EWTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Edgewise Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edgewise Therapeutics Inc Shares that will get you 0.1070 shares as per Edgewise Therapeutics Inc share price of $14.02 per share as on September 16, 2025 at 8:41 pm IST.

What is the minimum amount required to buy Edgewise Therapeutics Inc Stock (EWTX) from India?

Indian investors can start investing in Edgewise Therapeutics Inc (EWTX) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 8:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Edgewise Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 8:41 pm IST). Based on Edgewise Therapeutics Inc share’s latest price of $14.02 as on September 16, 2025 at 8:41 pm IST, you will get 0.7133 shares of Edgewise Therapeutics Inc. Learn more about fractional shares .